Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Acadesine

EU orphan designation number: EU/3/11/881   
Active ingredient: Acadesine
Indication: Treatment of multiple myeloma
Sponsor: Advancell - Advanced In Vitro Cell Technologies S.A.
Via Augusta 59, 3rd floor, door 313, E-08006 Barcelona, Espaņa

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/08/2011 Centralised Orphan - Designation EMA/OD/017/11 (2011)5806 of 05/08/2011
05/07/2013 Other procedure